Low serum and bone vitamin K status in patients with longstanding Crohn's disease: Another pathogenetic factor of osteoporosis in Crohn's disease?

Gut

Volumn 48, Issue 4, 2001, Pages 473-477

  Schoon, E J ^a   Muller M C A ^a   Vermeer, C ^b   Schurgers, L J ^b   Brummer, R J M ^a   Stockbrugger R W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Bone mineral density; Crohn's disease; Osteocalcin; Vitamin K

Indexed keywords

CALCIUM; OSTEOCALCIN; PREDNISOLONE; TRIACYLGLYCEROL; VITAMIN D; VITAMIN K GROUP;

ADULT; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; VITAMIN BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; BONE DENSITY; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROHN DISEASE; DENSITOMETRY, X-RAY; DURAPATITE; FEMALE; HUMANS; LINEAR MODELS; MALE; OSTEOCALCIN; OSTEOPOROSIS; RISK FACTORS; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; VITAMIN D; VITAMIN K DEFICIENCY;

EID: 0035080001     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.4.473     Document Type: Article

References (36)

1. Metabolic bone assessment in patients with inflammatory bowel disease
2. Reduced bone density in patients with inflammatory bowel disease
3. Osteoporosis in patients with inflammatory bowel disease
4. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis
5. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study
6. Low bone mineral density in patients with inflammatory bowel disease
7. Osteoporosis and determinants of bone density in patients with Crohn's disease
8. A controlled study of bone mineral density in patients with inflammatory bowel disease
9. Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography
10. Sex hormone status and bone metabolism in men with Crohn's disease
11. Nutrition and inflammatory bowel disease
12. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission
13. Vitamin D deficiency and bone disease in patients with Crohn's disease
14. Vitamin K nutrition and osteoporosis
15. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase
16. Role of vitamin K in bone metabolism
17. Long-term use of oral anticoagulants and the risk of fracture
18. Classification of inflammatory bowel disease
19. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
20. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause
21. Osteocalcin detection in aging serum and whole blood: Stability of different osteocalcin fractions
22. Nutritional intake of vitamins K1 (Phylloquinone) and K2 (Menaquinone) in the Netherlands
23. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer
24. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition
25. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group
26. Dietary induced subclinical vitamin K deficiency in normal human subjects
27. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease
28. Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease
29. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease
30. Bone disease in vitamin D-deficient patients with Crohn's disease
31. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders
32. Improved functional endpoints for use in vitamin K assessment: Important implications for bone disease
33. Effects of menatetrenone on prednisolone-induced bone loss in rats
34. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients
35. Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients
36. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis